MORGAN STANLEY - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 26 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,950
-20.0%
19,920
+10.7%
0.00%
Q2 2023$14,944
+482.4%
18,000
+200.0%
0.00%
Q4 2022$2,566
-14.5%
6,000
-0.0%
0.00%
Q3 2022$3,000
-70.0%
6,001
-17.2%
0.00%
Q2 2022$10,0007,249
+11783.6%
0.00%
Q1 2022$0
-100.0%
61
-99.8%
0.00%
Q4 2021$237,000
+23600.0%
28,678
+28578.0%
0.00%
Q3 2021$1,0001000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders